What is the Senores Pharmaceuticals Ltd share price today?

The share price of NSE:SENORES-EQ on 01 Oct 2026 (as of 15:04:50 IST) is ₹1347.

What is the NSE:SENORES-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:SENORES-EQ 52 week high low range shows a high of ₹1599 and a low of ₹684.6.

What is the Senores Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Senores Pharmaceuticals Ltd market cap is ₹63752000000.

What is the shareholding pattern of Senores Pharmaceuticals Ltd Stock?

The shareholding pattern of Senores Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 45.82% Foreign Institutional Investors (FII): 6.62% Domestic Institutional Investors (DII): 3.21% Mutual Funds: 6.56% Retail & Others: 37.79% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Senores Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Senores Pharmaceuticals Ltd is 50.4487, and the Price-to-Book (PB) ratio is 3.7395, as on 01 Oct 2026.

Senores Pharmaceuticals Share Price

1147.00+27.40 (+2.45%)

+48.73% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+2.45%

1 Week

-5.92%

1 Month

-15.01%

3 Month

-13.32%

6 Month

+23.10%

YTD

+39.50%

1 Year

+48.73%

5 Year

10 Year

Max

+91.17%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

1096.40

1053.40

906.60

706.00

High

1165.00

1228.00

1424.00

1599.00

About

Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

SENORESNSE

LTP

1W Low

1W High

Market cap (₹)

1769.9+8.9 (0.51%)

1722

1855

4,24,202Cr

10064+400 (4.14%)

9621.50

10064

2,64,141Cr

4650+70 (1.53%)

4532

4675

1,74,402Cr

2323+79 (3.52%)

2206.10

2441.90

1,26,811Cr

1240.6+56.2 (4.75%)

1182

1254.20

1,23,685Cr

1368.3+23.3 (1.73%)

1336.70

1368.30

1,11,868Cr

1396.9+38.9 (2.86%)

1357

1396.90

1,11,650Cr

2475+5.7 (0.23%)

2457.90

2528

1,02,196Cr

1694.5+34.6 (2.08%)

1647.20

1697.40

96,951Cr

2015.9+26 (1.31%)

1974

2033.80

91,301Cr

1133.1-86.1 (-7.06%)

1053.40

1228

5,157Cr

Senores Pharmaceuticals Share Price

1147.00+27.40 (+2.45%)

+48.73% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years162%

Last year59%

Compounded Profit Growth

10 years-

5 years-

3 years139%

Last year108%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year48%

Return on Equity

10 years15%

5 years15%

3 years17%

Last year14%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	162%	59%
-	-	139%	108%
-	-	-	48%
15%	15%	17%	14%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

SENORES

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
1,133.1	₹5157 Cr	38.63	8.58	37.09	₹115 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
₹192 Cr	₹180 Cr	₹175 Cr	₹175 Cr	₹154 Cr	₹133 Cr	₹114 Cr	₹103 Cr	₹101 Cr	₹80 Cr	₹102 Cr	₹79 Cr
₹9 Cr	₹3 Cr	₹18 Cr	₹4 Cr	₹13 Cr	₹9 Cr	₹12 Cr	₹5 Cr	₹2 Cr	₹48 L	₹2 Cr	₹80 L
₹201 Cr	₹183 Cr	₹193 Cr	₹178 Cr	₹167 Cr	₹141 Cr	₹126 Cr	₹108 Cr	₹102 Cr	₹81 Cr	₹104 Cr	₹80 Cr
₹145 Cr	₹136 Cr	₹137 Cr	₹128 Cr	₹120 Cr	₹110 Cr	₹100 Cr	₹82 Cr	₹81 Cr	₹63 Cr	₹84 Cr	₹67 Cr
₹67 Cr	₹57 Cr	₹65 Cr	₹58 Cr	₹55 Cr	₹38 Cr	₹31 Cr	₹31 Cr	₹25 Cr	₹22 Cr	₹24 Cr	₹16 Cr
₹9 Cr	₹7 Cr	₹8 Cr	₹5 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹3 Cr	₹2 Cr
₹48 Cr	₹39 Cr	₹47 Cr	₹45 Cr	₹41 Cr	₹26 Cr	₹21 Cr	₹20 Cr	₹16 Cr	₹13 Cr	₹18 Cr	₹10 Cr
₹37 Cr	₹30 Cr	₹37 Cr	₹34 Cr	₹30 Cr	₹21 Cr	₹18 Cr	₹16 Cr	₹13 Cr	₹11 Cr	₹14 Cr	₹7 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
—	—	—	—	—
₹46 Cr	₹46 Cr	₹31 Cr	₹10 Cr	₹9 Cr
₹29 L	₹0	₹0	₹0	₹0
₹887 Cr	₹740 Cr	₹174 Cr	₹36 Cr	₹28 Cr
₹887 Cr	₹740 Cr	₹174 Cr	₹36 Cr	₹28 Cr
₹934 Cr	₹786 Cr	₹204 Cr	₹45 Cr	₹37 Cr
₹31 Cr	₹26 Cr	₹27 Cr	₹0	₹0
₹111 Cr	₹81 Cr	₹28 Cr	₹0	₹20,000
₹83 Cr	₹82 Cr	₹106 Cr	₹30 Cr	₹12 Cr
₹59 L	-₹19 Cr	-₹15 Cr	₹2 Cr	-₹45 L
₹13 Cr	₹8 Cr	₹8 Cr	₹2 Cr	₹41 L
₹7 Cr	₹3 Cr	₹1 Cr	₹26 L	₹5 L
₹215 Cr	₹155 Cr	₹128 Cr	₹34 Cr	₹12 Cr
—	—	—	—	—
₹235 Cr	₹67 Cr	₹113 Cr	₹14 Cr	₹7 Cr
₹137 Cr	₹127 Cr	₹94 Cr	₹28 Cr	₹62 L
₹29 Cr	₹31 Cr	₹32 Cr	₹8 Cr	₹2 Cr
₹23 Cr	₹16 Cr	₹8 Cr	₹2 Cr	₹14 L
₹424 Cr	₹241 Cr	₹248 Cr	₹52 Cr	₹10 Cr
₹1604 Cr	₹1208 Cr	₹607 Cr	₹131 Cr	₹59 Cr
₹24 Cr	₹21 Cr	₹23 Cr	₹8 Cr	₹0
₹327 Cr	₹305 Cr	₹248 Cr	₹61 Cr	₹14 Cr
—	—	—	—	—
₹561 Cr	₹331 Cr	₹249 Cr	₹30 Cr	₹8 Cr
₹62 Cr	₹30 Cr	₹13 Cr	₹3 Cr	₹1 Cr
₹499 Cr	₹301 Cr	₹235 Cr	₹27 Cr	₹7 Cr
₹17 Cr	₹44 Cr	₹18 Cr	₹8 Cr	₹35 L
₹4 Cr	₹1 L	₹1 L	₹16 Cr	₹15 Cr
₹4 Cr	₹1 L	₹1 L	₹16 Cr	₹15 Cr
₹7 Cr	₹9 Cr	₹4 Cr	₹1 Cr	₹1 Cr
₹8 Cr	₹4 Cr	₹19 Cr	₹40 L	₹14 L
₹791 Cr	₹486 Cr	₹356 Cr	₹80 Cr	₹32 Cr
—	—	—	—	—
₹89 Cr	₹57 Cr	₹37 Cr	₹3 Cr	₹3 Cr
₹325 Cr	₹124 Cr	₹112 Cr	₹22 Cr	₹20 Cr
₹160 Cr	₹386 Cr	₹13 Cr	₹10 L	₹3 Cr
₹16 Cr	₹7 Cr	₹3 Cr	₹1 Cr	₹1 L
₹223 Cr	₹149 Cr	₹85 Cr	₹25 Cr	₹1 Cr
₹812 Cr	₹722 Cr	₹251 Cr	₹51 Cr	₹27 Cr
₹388 Cr	₹482 Cr	₹3 Cr	-₹55 L	₹17 Cr
₹1604 Cr	₹1208 Cr	₹607 Cr	₹131 Cr	₹59 Cr
₹203	₹171	₹67	₹46	₹42
₹203	₹171	₹67	₹46	₹42

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
₹159 Cr	₹71 Cr	₹25 Cr	₹12 Cr	₹1 Cr
₹58 Cr	₹27 Cr	₹18 Cr	₹3 Cr	₹1 Cr
-₹142 Cr	-₹134 Cr	-₹66 Cr	-₹15 Cr	-₹13 Cr
₹75 Cr	-₹37 Cr	-₹23 Cr	₹37 L	-₹10 Cr
₹62 Cr	-₹46 Cr	-₹26 Cr	-₹1 Cr	-₹10 Cr
-₹121 Cr	-₹429 Cr	-₹54 Cr	-₹48 Cr	-₹24 Cr
-₹1 Cr	₹573 Cr	₹87 Cr	₹46 Cr	₹36 Cr
-₹60 Cr	₹98 Cr	₹7 Cr	-₹3 Cr	₹2 Cr
₹105 Cr	₹8 Cr	₹10 L	₹3 Cr	₹2 Cr
₹1 L	₹0	₹50 L	₹0	₹0
₹46 Cr	₹105 Cr	₹8 Cr	₹10 L	₹3 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Senores Pharmaceuticals Share Price

1147.00+27.40 (+2.45%)

+48.73% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Open a free Demat account in minutes to start investing and screening .

Senores Pharmaceuticals Share Price

1147.00+27.40 (+2.45%)

+48.73% past 1 Year

Shareholding summary

Promoters

45.82%

FII

6.01%

DII

3.49%

7.36%

Others

37.32%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
45.82%	45.82%	45.82%	45.80%	45.80%	45.78%
6.01%	6.62%	3.64%	3.35%	4.28%	3.66%
3.49%	3.21%	4.55%	4.44%	5.08%	6.51%
7.36%	6.56%	5.07%	4.88%	3.54%	3.00%
37.32%	37.79%	40.92%	41.53%	41.30%	41.05%

Bulk & block deals

Name

Yashkumar Shantilal Sanghvi

Ravi Pawankumar Sanghvi

Astorne Capital Vcc Arven

Hrti Private Limited

Graviton Research Capital Llp

Hrti Private Limited

Graviton Research Capital Llp

Qe Securities Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
24 Dec 2025	Sell	21.88 Cr	₹792	2.76 L	Bulk	0.599888	BSE
24 Dec 2025	Sell	23.17 Cr	₹792.19	2.92 L	Bulk	0.63513	BSE
24 Dec 2025	Sell	39.61 Cr	₹792.12	5 L	Bulk	1.085691	NSE
29 Jul 2025	Sell	16.35 Cr	₹688.87	2.37 L	Bulk	0.515315	NSE
29 Jul 2025	Sell	21.81 Cr	₹689.98	3.16 L	Bulk	0.686355	NSE
29 Jul 2025	Purchase	21.79 Cr	₹689.33	3.16 L	Bulk	0.686355	NSE
29 Jul 2025	Purchase	18.49 Cr	₹686.66	2.69 L	Bulk	0.584675	NSE
24 Jul 2025	Purchase	43.79 Cr	₹684.96	6.39 L	Bulk	1.388133	NSE
24 Jul 2025	Purchase	16.77 Cr	₹686.01	2.44 L	Bulk	0.530677	NSE
24 Jul 2025	Sell	16.96 Cr	₹684.18	2.48 L	Bulk	0.538292	NSE

Insider trading & SAST

Client name

Ashokkumar Vijaysinh Barot

Dhananjay Barot

Dhananjay Ashokkumar Barot

Ashokkumar Vijaysinh Barot

Swapnil Jatin Shah & Others

Renosen Pharmaceuticals Private Limited

Sangeeta Mukur Barot

Swapnil Jatin Shah

Viraj Ashokkumar Barot

Ashokbhai Vijaysinh Barot

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
04 Sep 2026	Promoter	Acquisition	0.06	7.55	0	—	30 K	10 Aug 2026	Off Market / Inter se transfer	34,74,869	SAST	29(2)	—
04 Sep 2026	Promoter	Disposal	0.06	0.62	0	—	30 K	10 Aug 2026	Off Market / Inter se transfer	2,82,689	SAST	29(2)	—
12 Aug 2026	Promoter Group	Disposal	0.065141	0.62	0	—	30 K	10 Aug 2026	Off Market	2,82,689	Insider Trading	—	Equity
12 Aug 2026	Promoter	Acquisition	0.065141	7.55	0	—	30 K	10 Aug 2026	Off Market	34,74,869	Insider Trading	—	Equity
25 May 2026	Promoter	Acquisition	—	45.82	0	—	11.70 L	28 Mar 2026	Allotment Of Warrants On Preferential Basis	2,11,00,357	SAST	29(2)	—
01 Apr 2026	Promoter Group	Acquisition	1.604652	63.16	60.01 Cr	₹812	7.39 L	28 Mar 2026	Allotment	7,39,000	Insider Trading	—	Warrants
01 Apr 2026	Promoter Group	Acquisition	0.13354	5.26	4.99 Cr	₹812	61.50 K	28 Mar 2026	Allotment	61,500	Insider Trading	—	Warrants
01 Apr 2026	Promoter & Director	Acquisition	0.427762	16.84	16 Cr	₹812	1.97 L	28 Mar 2026	Allotment	1,97,000	Insider Trading	—	Warrants
01 Apr 2026	Promoter Group	Acquisition	0.107483	4.23	4.02 Cr	₹812	49.50 K	28 Mar 2026	Allotment	49,500	Insider Trading	—	Warrants
01 Apr 2026	Promoter & Director	Acquisition	0.26708	10.51	9.99 Cr	₹812	1.23 L	28 Mar 2026	Allotment	1,23,000	Insider Trading	—	Warrants

Senores Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Senores Pharmaceuticals Share Price

Senores Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Senores Pharmaceuticals Share Price

Senores Pharmaceuticals Share Price

Oscillators

Moving averages

Senores Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Senores Pharmaceuticals Share Price

Corporate Actions

Company details

Senores Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Senores Pharmaceuticals Share Price

News

Senores Pharmaceuticals Maintains Strong FY27 Revenue And Profit Growth Guidance

Senores Pharma Targets Government Channel Commercialization In H2 FY27

Senores Pharmaceuticals Approves Rs 43 Crore Subsidiary Expansion Plan

Senores Reports Stronger Second Quarter EBITDA And Margin

Senores Projects Strong Revenue And PAT Growth For FY27

Senores Reports Strong Second Quarter Revenue Growth Year On Year

Senores Q2 Consolidated Net Profit Rises 18.2 Percent Year On Year

Senores Pharma Board Approves Director Reappointments Pending Shareholder Approval

Senores Pharmaceuticals subsidiary Apnar Pharma clears routine USFDA GMP inspection

Senores Pharmaceuticals to expand operations into Mexico and Canada markets

Senores Pharmaceuticals to host analyst and investor meet on August 25

Senores Pharma announces FY27 capex plan to expand manufacturing capacity

Senores Pharma guided revenue target of Rs 2,500–3,000 crores in 3–4 years

Senores Pharma guides strong branded generics growth with profitability focus

Senores Pharma guides FY27 emerging market EBITDA margin at 18-20%

Senores Pharma issues FY27 guidance with strong revenue and PAT growth targets

Senores Pharma Q1 EBITDA nearly doubles YoY with strong margin expansion

Senores Pharma Q1 revenue rises sharply year-on-year to Rs 180 crores

Senores Pharma reports higher Q1 net profit at Rs 30.70 crores

Senores Pharmaceuticals to hold Q1FY27 earnings conference call on July 27

Senores Pharmaceuticals Ltd Share Price Today

Senores Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator